I don't know how you guys do that groovy cut and paste thing but this quote from you says it all.
Lars wrote:I don't know how you guys do that groovy cut and paste thing but this quote from you says it all.
Bob, you seem to be forgetting it IS a trial, and it does have a placebo arm. Until the trial is finished and the results are published, its possible (even though I too have great hope and faith in Tovaxin) it may not live up to expectations.Lyon wrote:At worst, keep in mind that no matter what happens, you're better off entering the trial than not having done so.
You cannot tell, as I am not "with you" or "against you". I'm on the rational, explore all options open until proven false. I think you feel "I am against you" because I will pull you up when you state an opinion as if it was a fact.Lyon wrote:I can never tell if you're arguing for or against me. This situation isn't unusual in that you quote one of my statements and then make a better argument for my case than I possibly could have.
HA! this is my jab at the fact you were assuming that the unproven Tovaxin process (within a trial setting) is the best treatment possible / available. My posts are probably confusing, as I too *think* it may be the case, but I also accept it is still medically unproven (I've done it again, haven't I...). Your post could of been made by an Opexa representative.Lyon wrote:To muddle matters a little further you throw in a little "touche" about me owning stock in Opexa.
You take away all the fun if you just lie down to die; although easier to poke if your not moving.Lyon wrote:It's common knowledge that I'm a little slow minded so please do me a favor and explain your thinking in a way that even I might understand.
I agree with you, so lets include all the odds. Including the chance that you are on placebo (30%? isn't it) so, the 90+% of Tovaxin (unproven) drops to that below the clinically proven effectiveness of Tysabri (>70% I think).Lyon wrote:Considering that there are no sure things in medically accepted treatment and that prospects might even be considered dismal, this might be seen as a situation in which the best one can do is to educate themselves in the research world and go with what they consider the best odds.
I NEVER said he would be better off, however, mathematically, over the term of the trial (2y?) another treatment such as Tysabri may have been better; mathematically. And to confuse you again, I would of jumped at the chance of Tovaxin, and so far have explicitly chosen NOT to try Tysabri; so I chose nothing over Tysabri.Lyon wrote:With it in mind that, win or lose, going with the best odds is a benefit in itself, how exactly do you figure Lou might have been better off by NOT entering the Tovaxin IIb trial?
CureOrBust wrote:I agree with you, so lets include all the odds. Including the chance that you are on placebo (30%? isn't it) so, the 90+% of Tovaxin (unproven) drops to that below the clinically proven effectiveness of Tysabri (>70% I think).
Users browsing this forum: No registered users